Condition
Epstein-Barr Virus (EBV) Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Epstein-Barr Virus (EBV) Infection clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Switzerland (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
VK-2019 for adults with relapsed or refractory EBV-positive diffuse large B‑cell lymphoma
This trial tests daily oral VK-2019 in adults with relapsed or refractory EBV-positive DLBCL to see if it is safe and can control the disease.
-
Investigating antibodies in primary Epstein-Barr virus infection
This study is trying to see how antibodies behave in people with a first-time Epstein-Barr virus infection and how it might relate to autoimmune diseases.
Related topics
Quick answers
How many Epstein-Barr Virus (EBV) Infection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.